Compare BVS & PACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BVS | PACB |
|---|---|---|
| Founded | 2011 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Biotechnology: Laboratory Analytical Instruments |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 482.9M | 555.5M |
| IPO Year | 2021 | 2010 |
| Metric | BVS | PACB |
|---|---|---|
| Price | $7.93 | $2.22 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 6 |
| Target Price | ★ $13.50 | $2.08 |
| AVG Volume (30 Days) | 245.7K | ★ 7.7M |
| Earning Date | 11-04-2025 | 02-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.15 | N/A |
| Revenue | ★ $563,829,000.00 | $154,584,000.00 |
| Revenue This Year | N/A | $4.19 |
| Revenue Next Year | $7.11 | $12.04 |
| P/E Ratio | $51.64 | ★ N/A |
| Revenue Growth | ★ 1.58 | N/A |
| 52 Week Low | $5.81 | $0.85 |
| 52 Week High | $11.25 | $2.73 |
| Indicator | BVS | PACB |
|---|---|---|
| Relative Strength Index (RSI) | 58.53 | 56.48 |
| Support Level | $7.56 | $1.84 |
| Resistance Level | $8.18 | $2.22 |
| Average True Range (ATR) | 0.31 | 0.17 |
| MACD | 0.03 | 0.05 |
| Stochastic Oscillator | 75.96 | 74.66 |
Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.